Format

Send to

Choose Destination
J Clin Microbiol. 2017 Jun;55(6):1970. doi: 10.1128/JCM.00525-17.

Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III".

Author information

1
Center for Biostatistics in AIDS Research and the Department of Biostatistics, Harvard University, Boston, Massachusetts, USA.
2
Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
3
Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
4
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
5
Public Health Research Institute Center, New Jersey Medical School-Rutgers University, Newark, New Jersey, USA.
6
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
7
German Center for Infection Research (DZIF), Partner Site Bonn, Cologne, Germany.
8
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
9
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
10
IBIS Biosciences Inc., an Abbott Company, Carlsbad, California, USA.
11
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
12
University of California, San Francisco General Hospital, San Francisco, California, USA.
13
Departments of Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center